MEDIFAST INC — Director's Dealing 2023

Jul 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-07-20

Reporting Person: Maloney James P. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-20	Common Stock	F	115	$94.50	Disposed	7205	Direct
2023-07-20	Common Stock	M	3574	—	Acquired	10779	Direct
2023-07-20	Common Stock	F	1027	$94.50	Disposed	9752	Direct

Footnotes

F1: 1,787 Performance Stock Units were granted on July 20, 2020, and vested on July 20, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors.